Retinal prostheses: Where to from here?. (17th June 2021)

• Record Type: Journal Article
• Authors: Allen, Penelope J.
• Is Part Of: Clinical & experimental ophthalmology. Volume 49:Number 5(2021)
• Page Start: 418
• Page End: 429
• Publication Date: 2021-06-17
• Subjects: research -- retinal prostheses -- retinitis pigmentosa; Ophthalmology -- Periodicals; 617.7
• DOI: 10.1111/ceo.13950
• Languages: English
• ISSNs: 1442-6404

Abstract

Abstract: Researchers have been working towards the development of retinal prostheses, so called "bionic eyes" since the 1960s in an effort to restore functional vision to severely visually impaired patients. Groups from all around the world are involved in this research but in particular, groups from the United States, Germany, France, Japan and Australia have conducted clinical trials of these devices and three of these devices have achieved either FDA HDE (U.S. Food and Drug Administration Humanitarian Device Exception) or CE mark approval for commercial production. Despite this, all three of these devices are now not in commercial production. There are many challenges to overcome to develop devices suitable to implant in human patients and then reach commercial distribution. This is an exacting process and many hurdles need to be overcome to reach this point so that leaving the market after achieving this goal is a significant decision. Ongoing research is exploring the possibility of less complicated surgery with better visual processing algorithms to provide more useful visual information for our patients to provide a commercial alternative.